Furthermore, we investigated the effect of inflammatory mediators involved in the pathogenesis of SSc, such as toll-like receptor (TLR) agonists [2,3] and interferon- (IFN-) as SSc is a type-I IFN disease [20]. The gene discussed is IFNA1; the disease is systemic sclerosis.